# Galectin Therapeutics Inc: Form 8-K, filed Mar 17, 2026

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2026-03-17
- Accepted by EDGAR: Mar 17, 2026, 11:50 ET
- Period: 2026-03-12
- Accession: 0001140361-26-009735
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036126009735/ef20068034_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036126009735/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036126009735/ef20068034_8k.htm

Filed Mar 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-009735. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.